Enanta Pharmaceuticals
ENTA
#8596
Rank
NZ$0.23 B
Marketcap
$11.10
Share price
7.17%
Change (1 day)
-21.37%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2024 (TTM): -NZ$0.18 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are NZ$67.63 Million. In 2023 the company made an earning of -NZ$0.23 Billion a decrease over its 2022 earnings that were of -NZ$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.18 Billion-23.31%
2023 -NZ$0.23 Billion4.39%
2022 -NZ$0.22 Billion-4.4%
2021 -NZ$0.23 Billion91.12%
2020 -NZ$0.12 Billion-407.13%
2019 NZ$38.46 M-78.63%
2018 NZ$0.18 B117.97%
2017 NZ$82.58 M-574.65%
2016 -NZ$17.4 Million-110.83%
2015 NZ$0.16 B-4.5%
2014 NZ$0.16 B-638.53%
2013 -NZ$31.25 Million-137.98%
2012 NZ$82.26 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$12.72 B-6,835.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.52 B-17,316.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.52 B-378.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.47 B-14,113.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$12.17 Billion 6,339.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.51 B-12,015.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland